Patents Assigned to SSV Therapeutics
  • Adamantanamines and Neramexane Salts of Thiomolybdic and Thiotungstic Acids
    Publication number: 20100216775
    Abstract: This invention concerns adamantanamines (e.g. memantine, amantadine, and rimantadine) and neramexane salts of thiomolybdic and thiotungstic acids, including their preparation and pharmaceutical compositions, as dual acting drugs. These salts are used to treat or potentially arrest the neurodegenerative pathophysiology, clinical signs and symptoms of dementia of the Alzheimer's type, Parkinson's, Huntington's, AIDS-related dementia and Schizophrenia and its cognitive deficits. Additional uses of these derivatives include antiviral activity.
    Type: Application
    Filed: February 21, 2008
    Publication date: August 26, 2010
    Applicant: SSV Therapeutics
    Inventor: Om P. Goel